Psilocybin Brain Rewiring: Lasting Relief After a Single Dose
- A new study from the University of Pennsylvania suggests psilocybin, the active compound in psychedelic mushrooms, can alter brain activity linked to chronic pain and co-occurring mental health...
- Chronic pain affects over 1.5 billion people globally [International Association for the Study of Pain],and is frequently intertwined with depression and anxiety.This complex relationship creates a feedback loop...
- Joseph Cichon, an assistant professor of Anesthesiology and Critical Care at Penn, investigated the effects of psilocybin on specific brain regions involved in pain processing and emotional regulation....
“`html
Psilocybin Shows Promise in Rewiring Brain Circuits for Chronic Pain Relief
Table of Contents
A new study from the University of Pennsylvania suggests psilocybin, the active compound in psychedelic mushrooms, can alter brain activity linked to chronic pain and co-occurring mental health conditions. Published in Nature Neuroscience on October 3, 2024, the research identifies specific brain circuits impacted by psilocybin, possibly paving the way for novel, non-opioid pain management strategies.
Last updated: October 3, 2024 at 06:31:32
The Chronic Pain & Mental Health Connection
Chronic pain affects over 1.5 billion people globally [International Association for the Study of Pain],and is frequently intertwined with depression and anxiety.This complex relationship creates a feedback loop where pain exacerbates mental health issues, and vice versa, considerably diminishing quality of life.Conventional treatments often struggle to address both aspects effectively.
How Psilocybin Impacts Brain Circuits
Researchers, led by Dr. Joseph Cichon, an assistant professor of Anesthesiology and Critical Care at Penn, investigated the effects of psilocybin on specific brain regions involved in pain processing and emotional regulation. The study utilized rodent models to observe changes in neuronal activity and synaptic plasticity following psilocybin administration.
The research pinpointed alterations in the anterior cingulate cortex (ACC) and the amygdala – brain areas crucial for pain perception, emotional processing, and decision-making. Psilocybin appeared to promote the formation of new connections between neurons, effectively “rewiring” these circuits. This rewiring correlated with reduced pain sensitivity and improved behavioral indicators of mood in the animal models.
Specifically, the study found that psilocybin increased synaptic plasticity in the ACC, suggesting an enhanced ability of the brain to adapt and modify its response to pain signals. Changes in the amygdala indicated a potential reduction in the emotional component of pain, often linked to anxiety and depression.
Rodent models and future Research
While the findings are promising, the researchers emphasize that this is preliminary work conducted in rodent models. Further investigation is needed to determine if these effects translate to humans and to understand the optimal dosage and long-term effects of psilocybin treatment.
“While these findings are encouraging, we don’t know how long-lived psilocybin’s effects are or how multiple doses might be needed to adjust brain pathways involved in chronic pain for a longer lasting solution,” adds Stephen Wisser, co-author and a Penn Neuroscience PhD student in Cichon’s lab.The team is planning future studies to explore these questions.
The study highlights the potential for psilocybin-assisted therapy as a novel approach to chronic pain management, particularly for individuals who have not responded to traditional treatments. Though, it’s crucial to note that psilocybin remains a Schedule I controlled substance in the united States, and its use is currently restricted to research settings.
Funding and Collaboration
The study was funded by the National Institutes of Health (grant R35GM151160-01) <